The following list includes updates posted to mayocliniclabs.com during the month of April:CPT Code and Test Classification Updates Test IDTest NameUpdatedCHOU9255Carbohydrate, UrineCPT Code Information4/27/2021 10:00amPMS270540PMS2 Immunostain, Technical Component OnlyTest Classification4/26/2021 3:04pmBRBPS65058Broad Range Bacterial PCR and Sequencing, VariesCPT Code Information4/26/2021 10:09amFLARP64718Free-Living Amebae, Molecular [...]
Andrew McKeon, M.B., B.Ch., M.D., discusses updates that are being made to Mayo Clinic Laboratories' autoimmune profile that will remove some antibodies from those profiles. He describes the rationale behind the updates, reviews which antibodies are involved, and explains how the changes will streamline testing and enhance test interpretation.
Christopher Klein, M.D., discusses Mayo Clinic’s updated myasthenia gravis and Lambert-Eaton syndrome testing approach. Automatic reflex to second-line testing saves time and increases sensitivity and specificity to confirm diagnosis in patients with atypical presentation.
The following list includes updates posted to mayocliniclabs.com during the month of March.
Audrey N., Schuetz, M.D., gives an overview of the new Staphylococcus Species Identification assay available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing compares to previous testing approaches, and what clinical action can be taken due to the results of this testing.
In February 2021, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
The following list includes updates posted to mayocliniclabs.com during the month of February.
Andrew McKeon, M,B., B.Ch., M.D., provides an overview of Mayo Clinic Laboratories' new paraneoplastic vision loss evaluation — a test that can help direct a cancer diagnosis and guide treatment. He reviews why this test was developed, when it should be ordered, and how the results can affect patient care.
In January, Mayo Clinic Laboratories announced a new test along with numerous reference value changes, obsolete tests, and algorithm changes.
Being able to identify SARS-CoV-2 in tissue is key to better understand the virus that causes COVID-19. Now, a first-of-its-kind test that detects SARS-CoV-2 in formalin-fixed, paraffin-embedded tissue is available from Mayo Clinic Laboratories.
David Murray, M.D., Ph.D., explains MASS-FIX — Mayo Clinic Laboratories' innovative approach to detecting monoclonal proteins that uses mass spectrometry rather than gel electrophoresis. This approach represents a significant step forward in plasma cell disorder screening and multiple myeloma treatment monitoring.
The following list includes updates posted to mayocliniclabs.com during the month of January.
Beginning Jan. 26, all air travelers entering the U.S. from other countries will need a negative COVID-19 test result before they can board their flights.